903 related articles for article (PubMed ID: 26012731)
1. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
[TBL] [Abstract][Full Text] [Related]
2. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
Isaacson SH; Skettini J
Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712
[TBL] [Abstract][Full Text] [Related]
3. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions.
Loavenbruck A; Sandroni P
Curr Med Res Opin; 2015 Nov; 31(11):2095-104. PubMed ID: 26373628
[TBL] [Abstract][Full Text] [Related]
4. Dysautonomia: A Forgotten Condition - Part 1.
Rocha EA; Mehta N; Távora-Mehta MZP; Roncari CF; Cidrão AAL; Elias Neto J
Arq Bras Cardiol; 2021 Apr; 116(4):814-835. PubMed ID: 33886735
[TBL] [Abstract][Full Text] [Related]
5. Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.
Isaacson SH; Dashtipour K; Mehdirad AA; Peltier AC
Curr Neurol Neurosci Rep; 2021 Mar; 21(4):18. PubMed ID: 33687577
[TBL] [Abstract][Full Text] [Related]
6. Chemical pharmacotherapy for the treatment of orthostatic hypotension.
Cheshire WP
Expert Opin Pharmacother; 2019 Feb; 20(2):187-199. PubMed ID: 30376728
[TBL] [Abstract][Full Text] [Related]
7. [Orthostatic hypotension and supine hypertension in pure autonomic failure].
Sartori M; Pessina AC
Ital Heart J Suppl; 2004 Nov; 5(11):879-83. PubMed ID: 15633433
[TBL] [Abstract][Full Text] [Related]
8. New developments in the management of neurogenic orthostatic hypotension.
Biaggioni I
Curr Cardiol Rep; 2014 Nov; 16(11):542. PubMed ID: 25303896
[TBL] [Abstract][Full Text] [Related]
9. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.
Kaufmann H; Freeman R; Biaggioni I; Low P; Pedder S; Hewitt LA; Mauney J; Feirtag M; Mathias CJ;
Neurology; 2014 Jul; 83(4):328-35. PubMed ID: 24944260
[TBL] [Abstract][Full Text] [Related]
10. Management of Orthostatic Hypotension in Parkinson's Disease.
Fanciulli A; Leys F; Falup-Pecurariu C; Thijs R; Wenning GK
J Parkinsons Dis; 2020; 10(s1):S57-S64. PubMed ID: 32716319
[TBL] [Abstract][Full Text] [Related]
11. Management of coexistent neurogenic orthostatic hypotension and supine hypertension.
Cannom DS
J Clin Hypertens (Greenwich); 2019 Nov; 21(11):1732-1734. PubMed ID: 31599484
[No Abstract] [Full Text] [Related]
12. Droxidopa in neurogenic orthostatic hypotension.
Kaufmann H; Norcliffe-Kaufmann L; Palma JA
Expert Rev Cardiovasc Ther; 2015; 13(8):875-91. PubMed ID: 26092297
[TBL] [Abstract][Full Text] [Related]
13. Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa.
Biaggioni I; Freeman R; Mathias CJ; Low P; Hewitt LA; Kaufmann H;
Hypertension; 2015 Jan; 65(1):101-7. PubMed ID: 25350981
[TBL] [Abstract][Full Text] [Related]
14. Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303).
Isaacson S; Shill HA; Vernino S; Ziemann A; Rowse GJ
J Parkinsons Dis; 2016 Oct; 6(4):751-759. PubMed ID: 27636856
[TBL] [Abstract][Full Text] [Related]
15. Droxidopa: a review of its use in symptomatic neurogenic orthostatic hypotension.
Keating GM
Drugs; 2015 Feb; 75(2):197-206. PubMed ID: 25559422
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Safety Considerations in the Treatment of Neurogenic Orthostatic Hypotension.
Olshansky B; Muldowney J
Am J Cardiol; 2020 May; 125(10):1582-1593. PubMed ID: 32204870
[TBL] [Abstract][Full Text] [Related]
17. Managed care approach to the treatment of neurogenic orthostatic hypotension.
Isaacson SH
Am J Manag Care; 2015 Oct; 21(13 Suppl):s258-68. PubMed ID: 26790110
[TBL] [Abstract][Full Text] [Related]
18. Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.
Baker J; Kimpinski K
CNS Drugs; 2017 Aug; 31(8):653-663. PubMed ID: 28702747
[TBL] [Abstract][Full Text] [Related]
19. Persistent unexplained chest pain and dyspnea in a patient with coronary artery disease: a case report.
Mobarek SK
BMC Cardiovasc Disord; 2020 Feb; 20(1):54. PubMed ID: 32019498
[TBL] [Abstract][Full Text] [Related]
20. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.
Gibbons CH; Schmidt P; Biaggioni I; Frazier-Mills C; Freeman R; Isaacson S; Karabin B; Kuritzky L; Lew M; Low P; Mehdirad A; Raj SR; Vernino S; Kaufmann H
J Neurol; 2017 Aug; 264(8):1567-1582. PubMed ID: 28050656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
